큐라티스
Human Candidate Non-clinical Phase I Phase II Phase III Remarks
TB vaccine
(ID93/GLA-SE)
Entered Phase II
(2017)
Diagnostic kit for
NTM
Cell therapeutics
Next generation
GLA R&D*
Chikungunya
vaccine*
Influenza vaccine*
Zika vaccine*
* Developing at IDRI
Animal CandidateNon-clinical Remarks
FMD vaccine Co-developed with
APQA
Adjuvant for other
diseases